Significant association between IL-32 gene polymorphisms and susceptibility to endometrial cancer in Chinese Han women

Endogenous IL-32 Controls Cytokine and HIV-1 Production

(2014) M. F. Nold et al.   JOURNAL OF IMMUNOLOGY

A promoter polymorphism in human interleukin-32 modulates its expression and influences the risk and the outcome of epithelial cell-derived thyroid carcinoma

(2013) T. S. Plantinga et al.   CARCINOGENESIS

Novel insights into the biology of interleukin-32

(2013) Leo A. B. Joosten et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

IL-32 with potential insights into rheumatoid arthritis

(2013) Wang-Dong Xu et al.   CLINICAL IMMUNOLOGY

Interleukin-32 contributes to invasion and metastasis of primary lung adenocarcinoma via NF-kappaB induced matrix metalloproteinases 2 and 9 expression

(2013) Qingli Zeng et al.   CYTOKINE

Role of interleukin-32 in chronic rhinosinusitis

(2012) Anjeni Keswani et al.   Current Opinion in Allergy and Clinical Immunology

Expression of IL-32 modulates NF-κB and p38 MAP kinase pathways in human esophageal cancer

(2012) Nasser Ghaly Yousif et al.   CYTOKINE

IL-1β promotes stemness and invasiveness of colon cancer cells through Zeb1 activation

(2012) Yijing Li et al.   Molecular Cancer

Dysregulation of overexpressed IL-32α in hepatocellular carcinoma suppresses cell growth and induces apoptosis through inactivation of NF-κB and Bcl-2

(2011) Yun Hee Kang et al.   CANCER LETTERS

Oncogenic KRAS-induced interleukin-8 overexpression promotes cell growth and migration and contributes to aggressive phenotypes of non-small cell lung cancer

(2011) Noriaki Sunaga et al.   INTERNATIONAL JOURNAL OF CANCER

Interleukin 32 (IL-32) Contains a Typical α-Helix Bundle Structure That Resembles Focal Adhesion Targeting Region of Focal Adhesion Kinase-1

(2011) Bas Heinhuis et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

IL-32γ inhibits cancer cell growth through inactivation of NF-κB and STAT3 signals

(2011) J H Oh et al.   ONCOGENE

Obesity, inflammatory markers, and endometrial cancer risk: a prospective case–control study

(2010) Laure Dossus et al.   ENDOCRINE-RELATED CANCER

Endometrial Cancer

(2010) Joel I. Sorosky   OBSTETRICS AND GYNECOLOGY

Expression of IL-32 in Human Lung Cancer Is Related to the Histotype and Metastatic Phenotype

(2009) Carlo Sorrentino et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Phospholipase A2-activating protein (PLAA) enhances cisplatin-induced apoptosis in HeLa cells

(2009) Fan Zhang et al.   CELLULAR SIGNALLING

Inflammation and oncogenesis: a vicious connection

(2009) Sergei I Grivennikov et al.   CURRENT OPINION IN GENETICS & DEVELOPMENT

Interleukin-32 Expression in the Pancreas

(2009) Atsushi Nishida et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Interleukin-6 induces an epithelial–mesenchymal transition phenotype in human breast cancer cells

(2009) N J Sullivan et al.   ONCOGENE

Interleukin-32 Promotes Osteoclast Differentiation but Not Osteoclast Activation

(2009) Guillaume Mabilleau et al.   PLoS One

IL-32, a Novel Proinflammatory Cytokine in Chronic Obstructive Pulmonary Disease

(2008) Fiorella Calabrese et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Anti-Tumor Necrosis Factor Therapy Inhibits Pancreatic Tumor Growth and Metastasis

(2008) J.-H. Egberts et al.   CANCER RESEARCH

Identification of the most active interleukin-32 isoform

(2008) Ji-Da Choi et al.   IMMUNOLOGY